Prestige Biopharma Limited

Quick facts

Phase 3 pipeline

• HD201 · Diabetes
  HD201 is a small molecule that targets the SGLT2 receptor.
• HD204 · Diabetes
  HD204 is a small molecule that targets the SGLT2 receptor.

Phase 1 pipeline

• EU-Herceptin
• EU-licensed Humira
• PBP1502
• US-Herceptin

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Prestige Biopharma Limited portfolio CI brief
• Prestige Biopharma Limited pipeline updates RSS